Lymphatic mapping with intralesional tracer administration in breast carcinoma patients

Lymphatic Mapping in Patients with Breast Carcinoma: Reproducibility of Lymphoscintigraphic Results

“…The 100% concordance for nodal basins, number of sentinel nodes, and sentinel node location in the present study reduces the likelihood of this explanation, despite the fact that intraindividual variability in radiocolloid uptake by the sentinel node was quite high. However, discrepancies with the blue dye method occur fairly frequently (22)(23)(24). This may be caused by the characteristics of the two tracers, the site of injection, and the injected volume.…”

Detección selectiva del ganglio centinela tras administración intratumoral del radiotrazador, en pacientes con cáncer de mama tratadas con quimioterapia neoadyuvante en relación con el grado de respuesta tumoral

“…Las vías profundas con administración intratumoral fueron descritas y publicadas por el grupo del centro nacional del cáncer holandés en el año 2000 27 . Se basa en la administración del radiocoloide en el interior del tumor.…”

Comparison of subareolar injection lymphoscintigraphy with the 1-day and the 2-day protocols for the detection of sentinel lymph nodes in patients with breast cancer

“…There was no significant difference between the 1-and 2-day protocols for the FNR or the NPV of the sentinel lymph node biopsy (p [ 0.05). However, the FNR of this study was higher than in previous studies [19][20][21]. The radiopharmaceutical used in this study was Tc-99m Tin-Colloid, which is the most commonly used commercially available radiopharmaceutical in Korea.…”